Eligible patients may pay as little as $0* per dose with the ILUMYA® Copay Card. Answer the questions below to help your patients save on their prescription and take advantage of all that ILUMYA® has to offer!
Only licensed healthcare professionals can enroll patients in the ILUMYA® Copay Program. Please enter your provider information.
Please refer to our Privacy Policy for more information.
*Subject to terms and conditions. Must be enrolled in ILUMYA SUPPORT® to qualify. Not valid for patients without commercial insurance coverage or if prescription is paid for by any state- or federally funded healthcare program, including but not limited to Medicare, Medicaid, VA, DOD, or TRICARE. Available to US, Guam, Virgin Islands, or Puerto Rico residents only. See the full terms and conditions for ILUMYA SUPPORT® programs at https://www.ILUMYA.com/savings.
By accepting this offer on behalf of your patient, you agree that if you are required to do so under the terms of their insurance coverage for this prescription or are otherwise required to do so by law, you will notify your patient’s insurance carrier of your redemption of this copay card. This offer is not valid with any other program, discount, incentive, or similar offer involving ILUMYA®. It is prohibited for any person to sell, purchase, or trade; offer to sell, purchase, or trade; or counterfeit this copay card.
What is the most important information I should know about ILUMYA® (tildrakizumab-asmn)?
Do not use ILUMYA if you have had a severe allergic reaction to ILUMYA or any of its ingredients.
Get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
ILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).
ILUMYA is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with ILUMYA and may treat you for TB before you begin treatment with ILUMYA if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with ILUMYA.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
Before receiving ILUMYA, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
It is not known if ILUMYA is safe and effective in children under 18 years of age.
What are the possible side effects of ILUMYA?
ILUMYA may cause serious side effects. See “What is the most important information I should know about ILUMYA?”
The most common side effects of ILUMYA include: upper respiratory infections, injection site reactions and diarrhea. These are not all of the possible side effects of ILUMYA. Call your doctor for medical advice about side effects.
You are encouraged to report any negative side effects of ILUMYA to FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or drug.safetyUSA@sunpharma.com (preferred) with as much information as available.
Please read the full Prescribing Information and Medication Guide for ILUMYA and discuss any questions with your doctor.
